Biomarkers in Cardiology - BIC-15: False positive and negative Troponin values of point of care measurements in the Emergency Department
- Conditions
- Troponin measurements from patients in the Emergency Department regardless what their chief complaints are.There is no need of specific chief complaints because the study does not aim at specific diseases.
- Registration Number
- DRKS00004823
- Lead Sponsor
- Charité - Universitätsmedizin BerlinMedizinische Klinik m.S. KardiologieArbeitsbereich Notfallmedizin CVK und CCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 4947
Inclusion Criteria
Patients in the Emergency Department that receive a Troponin measurement.
Exclusion Criteria
no exclusion criteria
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of measurement discrepancies utilizing parallel measurement of cardiac troponin T and I performed on the POCT device used in the emergency department (EDTA, AQT-90, Radiometer) and high sensitive troponin T performed in the central laboratory (lithium-heparin, Cobas, Roche). All measurements are performed during regular patient treatment.
- Secondary Outcome Measures
Name Time Method Detection and quantification of possible sample mixups in troponin measurements in the emergency department using described thresholds and additional measurement od the two biomarkers total protein and pseudocholinesterase. All measurements are performed during regular patient treatment.<br>Additionally a comparison of the diagnostic accuracy of the troponin tests used will be performed concerning the diagnosis of acute myocardial infarction. Theses analyses will be performed after finalized recruitment.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms cause false Troponin I results in point-of-care tests for ED patients?
How do point-of-care Troponin assays compare to central lab high-sensitivity methods in ED diagnostic accuracy?
Which cardiac biomarker panels predict false positive/negative Troponin outcomes in emergency cardiology?
What are the clinical implications of false Troponin measurements on acute coronary syndrome management in EDs?
Are alternative biomarkers like NT-proBNP or multimarker strategies improving cardiac risk stratification in EDs?